Coronavirus

Stanford creates virtual scientist to accelerate drug and vaccine discovery

Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.

ONS says schools in deprived areas had worse remote learning experiences

ONS data suggests that the difference between remote learning and classroom teaching was biggest for schools in deprived areas - with some teachers only able to contact 50% of their pupils.

Congo: Pathogen sequencing for infectious disease epidemics

Dr Placide Mbala-Kingebeni and Prof Jean-Jacques Muyembe Tamfum, discuss the contribution of pathogen sequencing in the management of infectious disease epidemics in the Democratic Republic of Congo.

UK approves COVID vaccination for 12-15 year olds

The UK's Chief Medical Officers have approved COVID vaccination for young people aged between 12-15 years old, to begin by 22 September, 2021.

Test & Trace: A permanent fixture in the new normal?

Now that we are living in a country that is largely free from Coronavirus restrictions, will Test & Trace remain part of our new normal? Rhian Gorecki, Research Manager at Walnut UNLIMITED explores here.

COVID and a year of telehealth

Rowan Pritchard Jones, Medical Director at St Helens and Knowsley Teaching Hospitals NHS Trust, discusses how telehealth has helped the hospital support its patients during COVID and beyond.

COVID-19 vaccines: Risks versus benefits

Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.

Impact of COVID-19 in African countries

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, offers preliminary context about the impact of the COVID-19 pandemic in most African countries, starting with lessons to be learned from previous outbreaks.

Report documents 17% higher rate of COVID death in North England

The Northern Health Science Alliance report says the North of England experienced a 17% higher rate of COVID death than the South - because of "higher deprivation and worse pre-pandemic health".

UK approves Pfizer and AstraZeneca for third COVID dose

The UK medicine regulator approved both Pfizer and AstraZeneca vaccines as a third COVID dose - for use in a new UK booster scheme.

Do breastfeeding mothers have COVID vaccine side effects?

Researchers found that breastfeeding mothers and their infants faced no significant COVID vaccine side effects from the Pfizer and Moderna vaccines.

Optimising infection control post-pandemic

Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.

Study reveals one in five older patients marked “do not resuscitate”

A study, published in BMJ Supportive & Palliative Care, found that one in five older, sick patients are recorded as "do not resuscitate" on admission.

Scientists begin work on COVID vaccines which can survive heat

Scientists at the University of California San Diego are developing COVID vaccines that can survive heat - using ideas from plants and bacteria.

COVID-19: Antibody levels for the double-jabbed are waning

Dr Quinton Fivelman, PhD, Chief Scientific Officer at London Medical Laboratory, reveals that antibody levels for the double-jabbed are now waning. He asks was the UK Government unwise to relax most COVID precautions in July?.

EU and AstraZeneca agree new deadline for vaccine deliveries

The EU have dropped their court case against AstraZeneca, as a new deadline for vaccine deliveries is agreed between the two parties.

Why are young people in the UK vaccine hesitant?

ONS data finds that young people are distrustful of the vaccine, the UK Government, and anyone encouraging vaccine take-up - alongside the perception that COVID will not threaten their lives.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders